The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The US FDA has approved lenacapavir, a biannual injection by Gilead, to prevent HIV, potentially revolutionizing the fight against the epidemic.

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first ... of new infections are in women, who often need protection they can use without ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step ... of new infections are in women, who often need protection they can use without ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot ... HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need ...

The U.S. has approved the world’s only twice-a-year shot ... in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection ...